Xiaoping Geng
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in ⓘ
- Hepatology 26
- Hepatocellular Carcinoma Treatment and Prognosis 21
- Surgery 37
- Cholangiocarcinoma and Gallbladder Cancer Studies 15
- Pancreatitis Pathology and Treatment 8
- Pediatric Hepatobiliary Diseases and Treatments 8
- Co-authors
- Yijun Zhao (21 shared papers)Fubao Liu (22 shared papers)Hongchuan Zhao (16 shared papers)He Li (1 shared paper)Weiwei Ge (1 shared paper)Ruolin Wu (7 shared papers)Fan Huang (9 shared papers)Lijie Feng (3 shared papers)
- Journals
- HPB (4 papers)Trials (4 papers)World Journal of Gastroenterology (4 papers)BMC Surgery (2 papers)BMC Cancer (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaoping Geng
76 papers receiving 867 citations
Peers
Comparison fields: 5 of 98
- Hepatology 159
- Cancer Research 181
- Oncology 205
- Surgery 246
- Pathology and Forensic Medicine 96
Countries citing papers authored by Xiaoping Geng
This map shows the geographic impact of Xiaoping Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Geng more than expected).
Fields of papers citing papers by Xiaoping Geng
This network shows the impact of papers produced by Xiaoping Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Geng. The network helps show where Xiaoping Geng may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Geng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 122 | |
| 2 | 2011 | 61 | |
| 3 | 2016 | 42 | |
| 4 | 2017 | 41 | |
| 5 | 2014 | 35 | |
| 6 | 2015 | 33 | |
| 7 | 2019 | 30 | |
| 8 | 2015 | 26 | |
| 9 | 2016 | 26 | |
| 10 | 2016 | 26 | |
| 11 | 2017 | 24 | |
| 12 | 2015 | 23 | |
| 13 | 2021 | 18 | |
| 14 | FOXA1 positively regulates gene expression by changing gene methylation status in human breast cancer MCF-7 cells. | 2015 | 18 |
| 15 | 2020 | 17 | |
| 16 | 2016 | 17 | |
| 17 | 2015 | 16 | |
| 18 | 2011 | 16 | |
| 19 | 2015 | 16 | |
| 20 | 2015 | 15 |
About Xiaoping Geng
Xiaoping Geng is a scholar working on Hepatology, Surgery, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 81 papers that have together received 886 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), Gallbladder and Bile Duct Disorders (12 papers), Pancreatic and Hepatic Oncology Research (12 papers), Liver Disease Diagnosis and Treatment (11 papers), Pancreatitis Pathology and Treatment (8 papers), Pediatric Hepatobiliary Diseases and Treatments (8 papers) and Cancer Mechanisms and Therapy (6 papers). The work is most often cited by research in Hepatology (159 citations), Cancer Research (181 citations), Oncology (205 citations), Surgery (246 citations) and Pathology and Forensic Medicine (96 citations). Xiaoping Geng has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yijun Zhao, Fubao Liu, Hongchuan Zhao, He Li, Weiwei Ge, Ruolin Wu, Fan Huang, Lijie Feng, Lei Huang and Yuxian Shen. Their work appears in journals such as HPB, Trials, World Journal of Gastroenterology, BMC Surgery and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.